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Dermatophytoses are the most common fungal infection worldwide with a non-
despicable impact in health-care costs. Trichophyton rubrum is an antropophilic 
dermatophyte species very well adapted to human host causing chronic and slowly 
progressing disease on keratinised tissues. It is the causative agents of about 70% 
of all human dermatophytoses. Besides their distribution all over the world this 
species is by far, the most frequently isolated species on onychomycosis and tinea 
pedis. Matrix Assisted Laser Desorption Ionisation Time of Flight Mass 
Spectrometry (MALDI-TOF MS) analysis has already been used as a rapid 
technique in the identification and classification of microorganisms. It has 
progressively been incorporated as a technique in the polyphasic approach to 
improve the accuracy of the microbial identification issue. This technique has also 
been used as a tool for the fast identification of filamentous fungi with clinical 
relevance including dermatophytes. In this study twenty clinical dermatophyte 
isolates were analysed using a polyphasic approach that was based on macro- and 
micro-morphologies, biochemistry, molecular biology using ITS 1-4 sequencing 
data and primers M13, (GACA)4 and (AC)10 for typing and, MALDI-TOF MS 
analyses. Eighteen of these clinical dermatophyte isolates were collected from 
human nails. The remaining 2 isolates were the reference strain T. rubrum ATCC 
MYA-4438 that was used as positive control and the strain T. mentagrophytes 
ATCC MYA-4439 that was used as out-group. Preliminary results based on macro- 
and micro-morphologies indicated that all isolates were T. rubrum. These results 
were confirmed by molecular biology and MALDI-TOF MS techniques. For 
molecular approach 16 T. rubrum isolates were clustered in a single group with 
100% of genotypic homology of the ITS1-4 region. Moreover, 2 remaining T. 
rubrum isolates were found having 98% of homology in this region. Similar 
clusters were found for M13 and (GACA)4 primers. In contrast, (AC)10 was not 
discriminative. MALDI-TOF MS analysis corroborates with morphological and 
molecular identifications. Nine T. rubrum isolates were clustered on a single group 
evidencing 100% similarity and the remaining T. rubrum isolates were distributed 
over the MALDI-TOF MS dendrogram showing phenotypic variability. MALDI-TOF 
MS shown to be as good as molecular biology and, moreover, rapid, low-cost and 
accurate alternative tool for identification and strain typing of T. rubrum clinical 
isolates. Analysis of mass spectra profiles provided new insights in the proteomic 
approach for strain typing of clinical isolates of T. rubrum. As a matter of 
consequence, MALDI-TOF MS can be suitable as point-of-care diagnostic for 
dermatophytoses. 
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